NCT06061120 Non-invasive Differentiation of Supraventricular Tachyarrhythmia
| NCT ID | NCT06061120 |
| Status | Recruiting |
| Phase | — |
| Sponsor | RWTH Aachen University |
| Condition | Supraventricular Arrhythmia |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,250 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2024-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,250 participants in total. It began in 2021-09-01 with a primary completion date of 2024-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
1. Questionnaire for supraventricular tachycardia: About history and targeted diagnosis of supraventricular tachycardia 2. Extended Signal-averaged ECG for detailed P-Wave analysis and to calculate a virtual atrial electrocardiogram (ECG)
Eligibility Criteria
Inclusion Criteria: * Scheduled for ablation of a supraventricular tachycardia (atrial fibrillation, typical atrial flutter, AV nodal reentry tachycardia, accessory pathway) * majority Exclusion Criteria: * Unstable patient with need for intensive medical care * Lack of language skills or limited cognitive abilities that prevent a differentiated anamnesis and information. Exclusion criteria for study section Questionnaire: \- Competing clinically present arrhythmias, including relevant supra- and ventricular extrasystole (\>5%/die). Exclusion criteria for study section Extended high-resolution ECG: * Previous electrophysiological ablation at the same site for atrial fibrillation. * Relevant supra- and ventricular extrasystole (\>5%/die). * Other clinically present arrhythmias are not excluded if they can be sequentially triggered and ablated (e.g. atrial fibrillation and atrial flutter). Since separate detection is possible with the high-resolution ECG. * Implanted active electrical device (e.g. pacemaker, defibrillator, deep brain pacemaker) * Allergy to measuring electrodes
Contact & Investigator
Matthias D Zink, MD
PRINCIPAL INVESTIGATOR
RWTH Aachen University
Frequently Asked Questions
Who can join the NCT06061120 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Supraventricular Arrhythmia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06061120 currently recruiting?
Yes, NCT06061120 is actively recruiting participants. Contact the research team at mzink@ukaachen.de for enrollment information.
Where is the NCT06061120 trial being conducted?
This trial is being conducted at Aachen, Germany.
Who is sponsoring the NCT06061120 clinical trial?
NCT06061120 is sponsored by RWTH Aachen University. The principal investigator is Matthias D Zink, MD at RWTH Aachen University. The trial plans to enroll 1,250 participants.